- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06875622
Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial)
Comparison of Behaviorally-Based Remote Approaches to Optimize Weight Loss and Identification of Factors Which Characterize Treatment Response
Study Overview
Status
Conditions
Detailed Description
Participants will be randomized at baseline to one of four weight loss intervention conditions: 1) automated program + coaching, 2) automated program + no coaching, 3) group videoconference program + coaching, and 4) group videoconference program + no coaching. All participants will be provided with weekly goals, instructed to self-monitor diet, exercise, and weight daily, and provided with feedback based upon these data. Those receiving the online program will also be instructed to view video lessons (24 in total, 10-15 min each) which focus on behavioral strategies for changing diet and exercise. Individuals randomized to the videoconference program will participate in 24 group sessions (1 hour each) designed to mimic in-person treatment and allow for participant interaction via large and small group discussions. The content across conditions will be similar and the lessons will be provided weekly during months 1-3, twice per month during months 4-6, and monthly during months 7-12. Those receiving coaching will have individual, monthly meetings with a coach via videoconference (~15 min each). Coaching sessions will focus on individual barriers, problem solving, goal setting, and fostering support and accountability.
The primary aim of this study is to examine the effects of delivery format (automated online vs. videoconference) and coaching (individualized vs. none) on weight loss at 12 months. Secondary aims will examine the effects of delivery format and coaching on intervention engagement (e.g., frequency of self-monitoring), psychosocial outcomes (e.g., perceived support, self-efficacy, and motivation), 18-month weight loss, and the cost per kilogram of weight loss (to examine whether the addition of human support is cost-effective). Two algorithms will also be developed to predict which treatment type should be recommended to whom, using only baseline characteristics: 1) a 'widely-applicable' algorithm which will use metrics common to electronic medical records (sex, BMI, age, race, ethnicity), and 2) a 'more comprehensive' algorithm which will further include additional baseline characteristics (e.g., education, household income, health literacy, group preference, etc).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jessica L Unick, PhD
- Phone Number: 401-793-8966
- Email: junick@brownhealth.org
Study Contact Backup
- Name: Jennifer Webster
- Phone Number: 401-793-8946
- Email: jwebster@brownhealth.org
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Recruiting
- The Miriam Hospital's Weight Control and Diabetes Research Center
-
Contact:
- Jessic Unick, PhD
- Phone Number: 401-793-8966
- Email: junick@brownhealth.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Body Mass Index between 25-45 kg/m2
- Daily, home Internet access
Exclusion Criteria:
- Currently pregnant, planning to become pregnant within the next 18 months, or pregnant within the past 6 months
- Current or recent enrollment (<2 years) in a weight loss program
- Presence of any medical condition for which exercise, weight loss, or dietary restriction is contraindicated
- Recent weight loss (≥10 pounds within the past 6 months)
- Currently taking weight loss medications or history of bariatric surgery
- Inability to walk 2 blocks without stopping
- Non-English speaking
- A member of one's household is participating in the study
- History of anorexia or bulimia nervosa
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Automated online program + coaching
Participants randomized to this condition will receive a 12-month automated weight loss program delivered via the Internet plus monthly, individual coaching sessions delivered via videoconference.
|
Participants receiving this program are given a daily calorie intake goal of 1200-1800 kcal/day based upon their starting weight and a moderate-intensity aerobic exercise (e.g., walking) goal which progresses to 250 min/week.
They are instructed to self-monitor body weight, calorie intake, and exercise minutes daily over 12 months, and are provided with a smart scale for electronic transmission of weight data.
Computer-generated, personalized feedback is based upon self-monitoring data, and provided weekly during months 1-3, twice per month during months 4-6, and monthly thereafter.
Participants are also instructed to view a new multi-media video lesson weekly during months 1-3, 2x/month during months 4-6, and monthly thereafter (24 lessons in total).
These videos are 10-15 minutes in duration and are intended to teach behavioral principles for losing weight, healthy eating, and exercise.
Participants will receive monthly, one-on-one coaching sessions (12 in total) throughout the 12-month intervention period.
Coaching sessions will be conducted via videoconference and the initial coaching session will be approximately 30 minutes and all remaining sessions will be approximately 15 minutes.
The structure of the coaching sessions will be similar across participants, but the content will be tailored to the individual.
Coaches will use goal setting, problem solving, and motivational interviewing to help facilitate adherence and achievement of weight loss program goals.
|
|
Experimental: Automated online program only
Participants randomized to this condition will receive a 12-month automated weight loss program delivered via the Internet.
|
Participants receiving this program are given a daily calorie intake goal of 1200-1800 kcal/day based upon their starting weight and a moderate-intensity aerobic exercise (e.g., walking) goal which progresses to 250 min/week.
They are instructed to self-monitor body weight, calorie intake, and exercise minutes daily over 12 months, and are provided with a smart scale for electronic transmission of weight data.
Computer-generated, personalized feedback is based upon self-monitoring data, and provided weekly during months 1-3, twice per month during months 4-6, and monthly thereafter.
Participants are also instructed to view a new multi-media video lesson weekly during months 1-3, 2x/month during months 4-6, and monthly thereafter (24 lessons in total).
These videos are 10-15 minutes in duration and are intended to teach behavioral principles for losing weight, healthy eating, and exercise.
|
|
Experimental: Group videoconference program + coaching
Participants randomized to this condition will receive a 12-month, group-based behavioral weight loss program delivered via videoconference plus monthly, individual coaching sessions delivered via videoconference.
|
Participants will receive monthly, one-on-one coaching sessions (12 in total) throughout the 12-month intervention period.
Coaching sessions will be conducted via videoconference and the initial coaching session will be approximately 30 minutes and all remaining sessions will be approximately 15 minutes.
The structure of the coaching sessions will be similar across participants, but the content will be tailored to the individual.
Coaches will use goal setting, problem solving, and motivational interviewing to help facilitate adherence and achievement of weight loss program goals.
Participants receiving this program will be instructed to attend interactive group videoconference sessions (60 minutes each) focused on behavioral strategies for changing diet and exercise to promote weight loss.
Classes will be weekly during months 1-3, twice per month during months 4-6, and monthly during months 7-12.
These classes are designed to allow participants to interact with, support, and learn from one another.
Participants are also given a daily calorie intake goal of 1200-1800 kcal/day based upon their starting weight and a moderate-intensity aerobic exercise (e.g., walking) goal which progresses to 250 min/week.
They are instructed to self-monitor body weight, calorie intake, and exercise minutes daily over 12 months, and are provided with a smart scale for electronic transmission of weight data.
Semi-automated, personalized feedback, based on self-monitoring data, is provided by the group instructor at the same frequency as group sessions are held.
|
|
Experimental: Group videoconference program only
Participants randomized to this condition will receive a 12-month, group-based behavioral weight loss program delivered via videoconference.
|
Participants receiving this program will be instructed to attend interactive group videoconference sessions (60 minutes each) focused on behavioral strategies for changing diet and exercise to promote weight loss.
Classes will be weekly during months 1-3, twice per month during months 4-6, and monthly during months 7-12.
These classes are designed to allow participants to interact with, support, and learn from one another.
Participants are also given a daily calorie intake goal of 1200-1800 kcal/day based upon their starting weight and a moderate-intensity aerobic exercise (e.g., walking) goal which progresses to 250 min/week.
They are instructed to self-monitor body weight, calorie intake, and exercise minutes daily over 12 months, and are provided with a smart scale for electronic transmission of weight data.
Semi-automated, personalized feedback, based on self-monitoring data, is provided by the group instructor at the same frequency as group sessions are held.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent weight change
Time Frame: 12 months
|
Weight change will be assessed via smart scales using weight at baseline and 12 months and calculated as follows: ([12-month weight minus baseline weight] / baseline weight * 100).
|
12 months
|
|
Change in perceived support
Time Frame: 12 months
|
Perceived support will be measured via the Important Others Questionnaire.
Scores on this questionnaire range from 12 to 84 with higher scores indicating a greater perception of support from important others.
Change in perceived support will be calculated as follows: 12-month perceived support minus baseline perceived support.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost per kilogram of weight loss
Time Frame: 12 months
|
The cost per participant to deliver the intervention will be calculated and divided by the average weight change (in kilograms) from baseline to 12 months.
|
12 months
|
|
Percent weight change
Time Frame: 18 months
|
Weight change will be assessed via smart scales using weight at baseline and 18 months and calculated as follows ([18 month weight minus baseline weight] / baseline weight * 100).
|
18 months
|
|
Frequency of self-monitoring weight
Time Frame: 12 months
|
The number of days that a participant stepped on the scale over the 12-month intervention period will be calculated.
|
12 months
|
|
Self-monitoring of calorie intake
Time Frame: 12 months
|
The number of days that a participant reported their calorie intake over the 12-month intervention period will be calculated.
|
12 months
|
|
Change in self-efficacy for diet
Time Frame: 12 months
|
Self-efficacy for diet will be measured via the Weight Efficacy Lifestyle Questionnaire.
Scores range from 0 to 80, with higher scores indicating greater self-efficacy.
Change in self-efficacy for diet will be calculated as 12-month score minus the baseline score.
|
12 months
|
|
Self-efficacy for exercise
Time Frame: 12 months
|
Self-efficacy for exercise will be measured via the Self-Efficacy for Exercise Scale.
Scores range from 0 to 90 with higher scores indicating greater self-efficacy.
Change in self-efficacy for exercise will be calculated as the 12-month score minus the baseline score.
|
12 months
|
|
Change in autonmous motivation
Time Frame: 12 months
|
Autonomous motivation will be measured via the Treatment Self-Regulation Questionnaire for Weight Management (autonomous motivation subscale).
Scores range from 6 to 42 and higher scores indicate more autonomous motivation.
Change in motivation will be calculated as the 12-month score minus the baseline score.
|
12 months
|
|
Change in controlled motivation
Time Frame: 12 months
|
Controlled motivation will be measured via the Treatment Self-Regulation Questionnaire for Weight Management (controlled motivation subscale).
Scores range from 6 to 42 and higher scores indicate more controlled motivation.
Change in motivation will be calculated as the 12-month score minus the baseline score.
|
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2185718
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity/therapy
-
Xiaguang DuanCompleted
-
Cristian AlvarezUniversidad de La FronteraCompleted
-
Universidad Autonoma de Nuevo LeonUniversidad de la SabanaActive, not recruitingPrevention and Control | Obesity/therapyMexico
-
University of Colorado, DenverUniversity of Minnesota; The Metis FoundationNot yet recruitingObesity/TherapyUnited States
-
Ruijin HospitalNot yet recruiting
-
The First Affiliated Hospital with Nanjing Medical...CompletedA Cholesterol Lowering Therapy of Focused Power Ultrasound Mediated Perirenal Fat Ablation (CONCISE)Dyslipidemias | Visceral Obesity | Ultrasound TherapyChina
-
University of SheffieldMid Yorkshire Hospitals NHS TrustWithdrawnObesity, Acceptance and Commitment Therapy, Weight Management ServiceUnited Kingdom
-
Nantes University HospitalCompletedMorbid Obesity | Ventilation Therapy; ComplicationsFrance
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedAdolescent | Obesity, Morbid | Drug Therapy | Bariatric Surgery | Young AdultUnited States
-
Washington University School of MedicineCompletedBinge Eating Disorder | Cognitive Therapy/Methods | Mental Disorders/Epidemiology | Obesity/Epidemiology | Obesity/TherapyUnited States
Clinical Trials on Automated online weight loss program
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesityUnited States
-
The Miriam HospitalUnknownObesity | OverweightUnited States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesityUnited States
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI)CompletedWeight Loss | Recruitment | Preeclampsia | Hypertension in Pregnancy | Diabetes Mellitus in Pregnancy | Postpartum Weight RetentionUnited States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of North Carolina, Chapel HillCompletedOverweight and ObesityUnited States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Unknown
-
Rush University Medical CenterCompleted
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); Healthways, Inc.Completed